We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Without Plaques, Alzheimer's Mice Recover

By Biotechdaily staff writers
Posted on 01 Feb 2005
The brain cells in a mouse model of Alzheimer's disease (AD) recovered rapidly after the characteristic brain plaques were removed, according to a new study conducted by researchers at Washington University School of Medicine (St. More...
Louis, MO, USA).

The researchers injected the mice with an antibody for a key component of brain plaques, the amyloid beta (Abeta) pepide. In areas where the antibodies cleared the plaques, many of the swellings observed on nerve cell branches rapidly disappeared. Prior to the experiment, many scientists believed plaque damage to nerve cells was something that only needed to happen once. The new findings suggest that the plaques might not only cause damage but also actively maintain it.

The mice used in the study had two mutations. One caused amyloid plaques to build up, while the second caused some of the mouse brain to produce a dye that allowed researchers to obtain detailed images of nerve cell branches. To correlate brain cell changes with plaque development, another dye was injected that temporarily sticks to amyloid. As the plaques appeared, nearby branches of nerve cells developed bumps and swellings. The swellings make it difficult or impossible for nerve-cell branches to send signals.

After showing that the number and size of the swellings were stable over the course of three to seven days, the Abeta antibodies were injected directly on the surface of the mouse brains. The plaques were cleared, and the swellings were monitored for three days. By then, there were no new swellings and there were 20-25% reductions in the number and size of the existing swellings. The largest swellings were least likely to heal.

"This provides confirmation of the potential benefits of plaque-clearing treatments and also gets us rethinking our theories on how plaques cause nerve-cell damage,” commented David H. Holzman, M.D., professor and head of the department of neurology at Washington University School of Medicine. The results of the study appear in the February 5, 2005, issue of the Journal of Clinical Investigation.




Related Links:
Washington U. Medical School

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LIAISON Murex Anti-HDV Immunoassay is the first fully automated FDA-authorized immunoassay for HDV detection in the U.S. (Photo courtesy of Diasorin)

Fully Automated Immunoassay Test Detects HDV Co‑Infection and Super-Infection

Hepatitis delta, also known as hepatitis D, is caused by the hepatitis delta virus (HDV). It is a viral liver infection that can result in one of the most severe forms of viral hepatitis.... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.